These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38292518)

  • 21. PPAR-α agonist elicits metabolically active brown adipocytes and weight loss in diet-induced obese mice.
    Rachid TL; Penna-de-Carvalho A; Bringhenti I; Aguila MB; Mandarim-de-Lacerda CA; Souza-Mello V
    Cell Biochem Funct; 2015 Jun; 33(4):249-56. PubMed ID: 25959716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PPAR-α agonists acutely inhibit Ca
    Chen H; Man RYK; Leung SWS
    Am J Physiol Heart Circ Physiol; 2018 Mar; 314(3):H681-H691. PubMed ID: 29127234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Baclofen for alcohol use disorder.
    Agabio R; Saulle R; Rösner S; Minozzi S
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD012557. PubMed ID: 36637087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the PPAR-α agonist fenofibrate on acute and short-term consequences of brain ischemia.
    Ouk T; Gautier S; Pétrault M; Montaigne D; Maréchal X; Masse I; Devedjian JC; Deplanque D; Bastide M; Nevière R; Duriez P; Staels B; Pasquier F; Leys D; Bordet R
    J Cereb Blood Flow Metab; 2014 Mar; 34(3):542-51. PubMed ID: 24398933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of combined PPAR-γ and PPAR-α agonist therapy on fructose induced NASH in rats: Modulation of gene expression.
    Abd El-Haleim EA; Bahgat AK; Saleh S
    Eur J Pharmacol; 2016 Feb; 773():59-70. PubMed ID: 26825546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PPAR agonists modulate human osteoclast formation and activity in vitro.
    Chan BY; Gartland A; Wilson PJ; Buckley KA; Dillon JP; Fraser WD; Gallagher JA
    Bone; 2007 Jan; 40(1):149-59. PubMed ID: 17010686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of pioglitazone and fenofibrate co-administration on bone biomechanics and histomorphometry in ovariectomized rats.
    Smith SY; Samadfam R; Chouinard L; Awori M; Bénardeau A; Bauss F; Guldberg RE; Sebokova E; Wright MB
    J Bone Miner Metab; 2015 Nov; 33(6):625-41. PubMed ID: 25534548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of single and combined PPAR-α and PPAR-γ activation on the neurological outcomes following cerebral ischemia reperfusion.
    Shehata AHF; Ahmed AF; Abdelrehim AB; Heeba GH
    Life Sci; 2020 Jul; 252():117679. PubMed ID: 32325134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PPAR Agonists: II. Fenofibrate and Tesaglitazar Alter Behaviors Related to Voluntary Alcohol Consumption.
    Blednov YA; Black M; Benavidez JM; Stamatakis EE; Harris RA
    Alcohol Clin Exp Res; 2016 Mar; 40(3):563-71. PubMed ID: 26857541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential influences of peroxisome proliferator-activated receptors gamma and -alpha on food intake and energy homeostasis.
    Larsen PJ; Jensen PB; Sørensen RV; Larsen LK; Vrang N; Wulff EM; Wassermann K
    Diabetes; 2003 Sep; 52(9):2249-59. PubMed ID: 12941763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting Peroxisome Proliferator-Activated Receptor-α (PPAR- α) to reduce paclitaxel-induced peripheral neuropathy.
    Caillaud M; Patel NH; White A; Wood M; Contreras KM; Toma W; Alkhlaif Y; Roberts JL; Tran TH; Jackson AB; Poklis J; Gewirtz DA; Damaj MI
    Brain Behav Immun; 2021 Mar; 93():172-185. PubMed ID: 33434562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential Roles of Peroxisome Proliferator-Activated Receptor-α and Receptor-γ on Renal Crystal Formation in Hyperoxaluric Rodents.
    Taguchi K; Okada A; Hamamoto S; Unno R; Kobayashi T; Ando R; Tozawa K; Gao B; Kohri K; Yasui T
    PPAR Res; 2016; 2016():9605890. PubMed ID: 27022389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Initial Evaluation of Fenofibrate for Efficacy in Aiding Smoking Abstinence.
    Perkins KA; Karelitz JL; Michael VC; Fromuth M; Conklin CA; Chengappa KN; Hope C; Lerman C
    Nicotine Tob Res; 2016 Jan; 18(1):74-8. PubMed ID: 25895948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preferential PPAR-α activation reduces neuroinflammation, and blocks neurodegeneration in vivo.
    Esmaeili MA; Yadav S; Gupta RK; Waggoner GR; Deloach A; Calingasan NY; Beal MF; Kiaei M
    Hum Mol Genet; 2016 Jan; 25(2):317-27. PubMed ID: 26604138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peroxisome proliferator-activated receptor (PPAR)-alpha activation prevents diabetes in OLETF rats: comparison with PPAR-gamma activation.
    Koh EH; Kim MS; Park JY; Kim HS; Youn JY; Park HS; Youn JH; Lee KU
    Diabetes; 2003 Sep; 52(9):2331-7. PubMed ID: 12941773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peroxisome proliferator-activated receptor-alpha agonist fenofibrate regulates IL-12 family cytokine expression in the CNS: relevance to multiple sclerosis.
    Xu J; Racke MK; Drew PD
    J Neurochem; 2007 Dec; 103(5):1801-10. PubMed ID: 17727629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Development of a cell-based peroxisome proliferator-activated receptors (PPARs) screening model and its application for evaluation of triterpenoids isolate from Alismatis Rhizoma].
    Li XY; Wang XH; Huang XQ; Wu TT; Xu W; Wu SS
    Zhongguo Zhong Yao Za Zhi; 2016 Nov; 41(21):4015-4022. PubMed ID: 28929690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-Hypertensive Action of Fenofibrate via UCP2 Upregulation Mediated by PPAR Activation in Baroreflex Afferent Pathway.
    Guan J; Zhao M; He C; Li X; Li Y; Sun J; Wang W; Cui YL; Zhang Q; Li BY; Qiao GF
    Neurosci Bull; 2019 Feb; 35(1):15-24. PubMed ID: 30173356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On the mechanism for PPAR agonists to enhance ABCA1 gene expression.
    Ogata M; Tsujita M; Hossain MA; Akita N; Gonzalez FJ; Staels B; Suzuki S; Fukutomi T; Kimura G; Yokoyama S
    Atherosclerosis; 2009 Aug; 205(2):413-9. PubMed ID: 19201410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of peroxisome proliferator-activated receptor activators on tumor necrosis factor-alpha expression in neonatal rat cardiac myocytes.
    Ye P; Fang H; Zhou X; He YL; Liu YX
    Chin Med Sci J; 2004 Dec; 19(4):243-7. PubMed ID: 15669179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.